Simplex Trading’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,500
Closed -$484K 10248
2023
Q2
$484K Buy
11,500
+7,000
+156% +$283K ﹤0.01% 3351
2023
Q1
$160K Buy
4,500
+4,300
+2,150% +$156K ﹤0.01% 4590
2022
Q4
$7K Sell
200
-100
-33% -$3.95K ﹤0.01% 7887
2022
Q3
$14K Buy
+300
New +$19.4K ﹤0.01% 7945
2022
Q1
Sell
-100
Closed -$10K 11719
2021
Q4
$10K Hold
100
﹤0.01% 9079
2021
Q3
$8K Hold
100
﹤0.01% 9082
2021
Q2
$8K Buy
+100
New +$8.45K ﹤0.01% 9258
2021
Q1
Sell
-10
Closed -$68K 10354
2020
Q4
$68K Sell
10
-50
-83% -$3.12K ﹤0.01% 5849
2020
Q3
$318K Buy
+60
New +$3.57K ﹤0.01% 3538
2020
Q1
Sell
-1
Closed -$5K 8481
2019
Q4
$5K Buy
+1
New +$54 ﹤0.01% 6730
2019
Q2
Sell
-61
Closed -$315K 8015
2019
Q1
$315K Buy
+61
New +$2.96K ﹤0.01% 3144
2018
Q4
Sell
-186
Closed -$958K 8050
2018
Q3
$958K Buy
+186
New +$9.11K ﹤0.01% 1938

Other funds holding SYNH

Simplex Trading's SYNH Position: Q2 2023 in Review

Simplex Trading sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 3,537 shares — an estimated $143K sold.

Simplex Trading first reported a position in SYNH in Q4 2015 and held it in 14 quarters. The position peaked at $1.94M in Q4 2022. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Simplex Trading reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 3,537 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $143K.
  • Simplex Trading first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 14 quarters.
  • Simplex Trading's Syneos Health, Inc. Class A Common Stock position peaked at $1.94M in Q4 2022.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.